Results 221 to 230 of about 1,527,044 (297)
Comparison of self-reported survey and wastewater-based epidemiology measures of cocaine use on a college campus. [PDF]
McCulloch S +3 more
europepmc +1 more source
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung +7 more
wiley +1 more source
Retraction Note: Case report on successful treatment for brain abscess in a Japanese monkey (Macaca fuscata). [PDF]
Kimura T.
europepmc +1 more source
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
Motor-cognitive analysis of dual task walking in chronic obstructive pulmonary disease patients: An observational study using functional near infrared spectroscopy. [PDF]
Hassan AS +4 more
europepmc +1 more source
Objective Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of uric acid (FEUA) also modulates this response and relates to oxypurinol concentrations.
Pascal Richette +13 more
wiley +1 more source
Adjusting for truncated study duration in recurrent event analysis: A weighting approach for clinical trials. [PDF]
Michael Raj A J, Thomas T, Dwarkanath P.
europepmc +1 more source
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink +3 more
wiley +1 more source

